Literature DB >> 12742299

Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death?

Raymond J Kim, Robert M Judd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12742299     DOI： 10.1016/s0735-1097(03)00190-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  31 in total

Review 1.  Hypertrophic cardiomyopathy.

Authors:  Carolyn Y Ho
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

2.  Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy.

Authors:  Elif Elmas; Christina Doesch; Stephan Fluechter; Miriam Freundt; Christel Weiss; Siegfried Lang; Thorsten Kälsch; Dariush Haghi; Jana Papassotiriou; Jan Kunde; Stefan O Schoenberg; Martin Borggrefe; Theano Papavassiliu
Journal:  Int J Cardiovasc Imaging       Date:  2010-09-26       Impact factor: 2.357

Review 3.  Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance.

Authors:  Annamalai Senthilkumar; Maulik D Majmudar; Chetan Shenoy; Han W Kim; Raymond J Kim
Journal:  Heart Fail Clin       Date:  2009-07       Impact factor: 3.179

4.  Extent of late gadolinium enhancement at right ventricular insertion points in patients with hypertrophic cardiomyopathy: relation with diastolic dysfunction.

Authors:  Yinsu Zhu; Eun-Ah Park; Whal Lee; Hyung-Kwan Kim; Ajung Chu; Jin Wook Chung; Jae Hyung Park
Journal:  Eur Radiol       Date:  2015-01-18       Impact factor: 5.315

Review 5.  Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies.

Authors:  Maythem Saeed; Steven W Hetts; Robert Jablonowski; Mark W Wilson
Journal:  World J Cardiol       Date:  2014-11-26

6.  Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy.

Authors:  Lu Fang; Andris H Ellims; Anna L Beale; Andrew J Taylor; Andrew Murphy; Anthony M Dart
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

7.  Myocardial Native T1 Time in Patients With Hypertrophic Cardiomyopathy.

Authors:  Shingo Kato; Shiro Nakamori; Steven Bellm; Jihye Jang; Tamer Basha; Martin Maron; Warren J Manning; Reza Nezafat
Journal:  Am J Cardiol       Date:  2016-07-18       Impact factor: 2.778

8.  Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy.

Authors:  Stephan Fluechter; Jürgen Kuschyk; Christian Wolpert; Christina Doesch; Christian Veltmann; Dariusch Haghi; Stefan O Schoenberg; Tim Sueselbeck; Tjeerd Germans; Florian Streitner; Martin Borggrefe; Theano Papavassiliu
Journal:  J Cardiovasc Magn Reson       Date:  2010-05-21       Impact factor: 5.364

9.  Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.

Authors:  Giovanni Donato Aquaro; Vincenzo Positano; Alessandro Pingitore; Elisabetta Strata; Gianluca Di Bella; Francesco Formisano; P Spirito; Massimo Lombardi
Journal:  J Cardiovasc Magn Reson       Date:  2010-04-07       Impact factor: 5.364

10.  Detection of myocardial damage in patients with sarcoidosis.

Authors:  Manesh R Patel; Peter J Cawley; John F Heitner; Igor Klem; Michele A Parker; Wael A Jaroudi; Trip J Meine; James B White; Michael D Elliott; Han W Kim; Robert M Judd; Raymond J Kim
Journal:  Circulation       Date:  2009-11-02       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.